997 related articles for article (PubMed ID: 12495545)
21. NSAID inhibition of GI cancer growth: clinical implications and molecular mechanisms of action.
Husain SS; Szabo IL; Tamawski AS
Am J Gastroenterol; 2002 Mar; 97(3):542-53. PubMed ID: 11922545
[TBL] [Abstract][Full Text] [Related]
22. Ibuprofen inhibits survival of bladder cancer cells by induced expression of the p75NTR tumor suppressor protein.
Khwaja F; Allen J; Lynch J; Andrews P; Djakiew D
Cancer Res; 2004 Sep; 64(17):6207-13. PubMed ID: 15342406
[TBL] [Abstract][Full Text] [Related]
23. Dose-dependent immunomodulatory effects of acetylsalicylic acid and indomethacin in human whole blood: potential role of cyclooxygenase-2 inhibition.
Härtel C; von Puttkamer J; Gallner F; Strunk T; Schultz C
Scand J Immunol; 2004 Oct; 60(4):412-20. PubMed ID: 15379866
[TBL] [Abstract][Full Text] [Related]
24. Anti-inflammatory drugs suppress proliferation and induce apoptosis through altering expressions of cell cycle regulators and pro-apoptotic factors in cultured human osteoblasts.
Chang JK; Li CJ; Liao HJ; Wang CK; Wang GJ; Ho ML
Toxicology; 2009 Apr; 258(2-3):148-56. PubMed ID: 19428934
[TBL] [Abstract][Full Text] [Related]
25. NSAIDs and breast cancer: a possible prevention and treatment strategy.
Agrawal A; Fentiman IS
Int J Clin Pract; 2008 Mar; 62(3):444-9. PubMed ID: 18194278
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological management of acute radiation morbidity.
Zimmermann JS; Kimmig B
Strahlenther Onkol; 1998 Nov; 174 Suppl 3():62-5. PubMed ID: 9830460
[TBL] [Abstract][Full Text] [Related]
27. In vivo and in vitro radioprotective effects of the prostaglandin E1 analogue misoprostol in DNA repair-proficient and -deficient rodent cell systems.
van Buul PP; van Duyn-Goedhart A; Sankaranarayanan K
Radiat Res; 1999 Oct; 152(4):398-403. PubMed ID: 10477916
[TBL] [Abstract][Full Text] [Related]
28. Diclofenac, a non-steroidal anti-inflammatory drug, suppresses apoptosis induced by endoplasmic reticulum stresses by inhibiting caspase signaling.
Yamazaki T; Muramoto M; Oe T; Morikawa N; Okitsu O; Nagashima T; Nishimura S; Katayama Y; Kita Y
Neuropharmacology; 2006 Apr; 50(5):558-67. PubMed ID: 16388830
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of cutaneous ultraviolet light B-mediated inflammation and tumor formation with topical celecoxib treatment.
Wilgus TA; Koki AT; Zweifel BS; Kusewitt DF; Rubal PA; Oberyszyn TM
Mol Carcinog; 2003 Oct; 38(2):49-58. PubMed ID: 14502644
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo.
Schwock J; Pham NA; Cao MP; Hedley DW
Cancer Chemother Pharmacol; 2008 Apr; 61(4):669-81. PubMed ID: 17579866
[TBL] [Abstract][Full Text] [Related]
31. Combination of radiation and celebrex (celecoxib) reduce mammary and lung tumor growth.
Liu W; Chen Y; Wang W; Keng P; Finkelstein J; Hu D; Liang L; Guo M; Fenton B; Okunieff P; Ding I
Am J Clin Oncol; 2003 Aug; 26(4):S103-9. PubMed ID: 12902866
[TBL] [Abstract][Full Text] [Related]
32. [Radiation protectants of the crystalline lens].
Belkacémi Y; Pasquier D; Castelain B; Warnet JM; Lartigau E
Cancer Radiother; 2003 Nov; 7 Suppl 1():49s-54s. PubMed ID: 15124544
[TBL] [Abstract][Full Text] [Related]
33. Amelioration of the pathological changes induced by radiotherapy in normal tissues.
Rezvani M
J Pharm Pharmacol; 2008 Aug; 60(8):1037-48. PubMed ID: 18644196
[TBL] [Abstract][Full Text] [Related]
34. Sphingosine-1-phosphate protects proliferating endothelial cells from ceramide-induced apoptosis but not from DNA damage-induced mitotic death.
Bonnaud S; Niaudet C; Pottier G; Gaugler MH; Millour J; Barbet J; Sabatier L; Paris F
Cancer Res; 2007 Feb; 67(4):1803-11. PubMed ID: 17308123
[TBL] [Abstract][Full Text] [Related]
35. Cyclooxygenase inhibitors induce apoptosis in oral cavity cancer cells by increased expression of nonsteroidal anti-inflammatory drug-activated gene.
Kim KS; Yoon JH; Kim JK; Baek SJ; Eling TE; Lee WJ; Ryu JH; Lee JG; Lee JH; Yoo JB
Biochem Biophys Res Commun; 2004 Dec; 325(4):1298-303. PubMed ID: 15555568
[TBL] [Abstract][Full Text] [Related]
36. Cyclooxygenase-2 as a target for anticancer drug development.
Méric JB; Rottey S; Olaussen K; Soria JC; Khayat D; Rixe O; Spano JP
Crit Rev Oncol Hematol; 2006 Jul; 59(1):51-64. PubMed ID: 16531064
[TBL] [Abstract][Full Text] [Related]
37. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
[TBL] [Abstract][Full Text] [Related]
38. NSAIDs suppress the expression of claudin-2 to promote invasion activity of cancer cells.
Mima S; Takehara M; Takada H; Nishimura T; Hoshino T; Mizushima T
Carcinogenesis; 2008 Oct; 29(10):1994-2000. PubMed ID: 18586689
[TBL] [Abstract][Full Text] [Related]
39. Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibition.
Totzke G; Schulze-Osthoff K; Jänicke RU
Oncogene; 2003 Sep; 22(39):8021-30. PubMed ID: 12970750
[TBL] [Abstract][Full Text] [Related]
40. Combination treatment with arsenic trioxide and irradiation enhances apoptotic effects in U937 cells through increased mitotic arrest and ROS generation.
Ho SY; Chen WC; Chiu HW; Lai CS; Guo HR; Wang YJ
Chem Biol Interact; 2009 May; 179(2-3):304-13. PubMed ID: 19159621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
